Drug Profile
FP 009
Alternative Names: FP009Latest Information Update: 28 Feb 2020
Price :
$50
*
At a glance
- Originator Foresee Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Chronic wounds
Most Recent Events
- 28 Feb 2020 No recent reports of development identified for research development in Chronic-wounds in USA
- 12 Jan 2016 Early research in Chronic wounds in USA (unspecified route) prior to January 2016 (Foresee Pharmceuticals pipeline, January 2016)